Marshall Wace’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Marshall Wace’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,900	Closed	-$203K	–	2768
2023 Q3	$203K	Buy	+19,900	New	+$152K	﹤0.01%	1974
2022 Q2	–	Sell	-16,810	Closed	-$107K	–	3992
2022 Q1	$107K	Sell	16,810 -1,142	-6%	-$6.15K	﹤0.01%	3191
2021 Q4	$112K	Buy	+17,952	New	+$140K	﹤0.01%	3356

Marshall Wace's THRN Position: Q4 2023 in Review

Marshall Wace sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 19,900 shares — an estimated $203K sold.

Marshall Wace first reported a position in THRN in Q4 2021 and held it in 3 quarters. The position peaked at $203K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Marshall Wace reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Marshall Wace sold 19,900 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $203K.
Marshall Wace first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Marshall Wace's Thorne Healthtech, Inc. Common Stock position peaked at $203K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.